Skip to Main Content

Paper Details

Atovaquone for treatment of COVID-19: A prospective randomized, double-blind, placebo-controlled clinical trial.
Front Pharmacol
3
2022
Atovaquone, COVID-19, COVID-19 infection, Patients, RNA, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2 main protease, atovaquone, dexamethasone, mice, patients, remdesivir
Author NameAffiliation
Chao XingMcDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center
Chao XingMcDermott Center for Human Growth and Development, University of Texas Southwestern Medical Center
  • 1 - 2

Datasets

Release 1.2